Pfizer, BioNTech Defeat Moderna COVID Jab Patent
Pfizer and BioNTech have convinced European appellate officials to nix a Moderna patent for a COVID-19 jab, after showing that its patented claims added details that weren't in the original application about...To view the full article, register now.
Already a subscriber? Click here to view full article